Niagen Bioscience (NAGE) vs SNDL (SNDL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
SNDL (SNDL) has outperformed Niagen Bioscience (NAGE) over the past year, losing 56.7% versus a loss of 64.4%. Over five years, NAGE leads with a -57.7% price change compared with -81.4% for SNDL. SNDL is the larger company by market cap ($300.3 million vs $212.8 million), about 1.4 times the size.
On valuation, Niagen Bioscience trades at a lower forward P/E (26.9x vs 40.7x for SNDL).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | SNDL |
|---|---|---|
| Share price | $2.69 | $1.22 |
| Market cap | $212.85M | $300.27M |
| 1-day change | +1.13% | 0.00% |
| YTD return | -57.70% | -26.51% |
| 1-year return | -64.42% | -56.66% |
| 5-year return | -57.70% | -81.40% |
| P/E ratio (TTM) | 14.16 | — |
| Forward P/E | 26.90 | 40.67 |
| EPS (TTM) | $0.19 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $2.60 |
| 52-week low | $2.61 | $1.17 |
| Distance from 52-week high | -66.16% | -53.04% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +349.07% | +184.43% |
| Average volume | 588.55K | 1.53M |
| Shares outstanding | 79.13M | 246.12M |
| Employees | 117 | 2,751 |
| Sector | Consumer Defensive | Health Care |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Niagen Bioscience in Consumer Defensive and SNDL in Health Care.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Consumer Defensive · Packaged Foods · 117 employees
About SNDL
SNDL stock →SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.
Health Care · Medicinal Chemicals and Botanical Products · 2,751 employees
NAGE vs SNDL FAQ
Which is bigger, Niagen Bioscience or SNDL?
SNDL (SNDL) is larger, with a market capitalization of $300.27M compared with $212.85M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or SNDL?
SNDL returned -56.66% over the past 12 months, compared with -64.42% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Niagen Bioscience and SNDL in the same industry?
No. Niagen Bioscience is in the Consumer Defensive sector, while SNDL is in Health Care.